ConductScience.org, home

Paper12945875

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.

Alikhan R and 9 others. Blood Coagul Fibrinolysis, 2003. Cited by 193 papers, by iCite.

Cite this record

ConductScience Library. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Papers, record 12945875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12945875

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.
PubMed
Journal
Blood Coagul Fibrinolysis
PubMed
Year
2003
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
193
iCite
Relative citation ratio, by iCite
4.97
iCite
Revised in PubMed
2022-04-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alikhan RRaza
2Cohen ATAlexander T
3Combe SSophie
4Samama MMMeyer M
5Desjardins LLouis
6Eldor AAmiram
7Janbon CCharles
8Leizorovicz AAlain
9Olsson CGCarl-Gustav
10Turpie AGAlexander G G

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticoagulantsMajor topic
EnoxaparinMajor topic
Venous ThrombosisMajor topic
Aged
Aged, 80 and over
Chronic Disease
Dose-Response Relationship, Drug
Double-Blind Method
Female
Heart Failure
Humans
Male
Middle Aged
Movement
Multicenter Studies as Topic
Neoplasms
Obesity
Randomized Controlled Trials as Topic
Respiratory Insufficiency
Thromboembolism
Treatment Outcome
Varicose Veins
Walking

Source PubMed

Download CSV of topics

Cited by64

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 193 citations.

PMIDTitleJournalYearIn PapersSource
42479201Pharmacological thromboprophylaxis in hospitalized patients with acute infectious diseases: a meta-analysis.Eur J Clin Pharmacol2026https://conductscience.org/library/papers/42479201PubMed
40108695The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial.Thromb J2025https://conductscience.org/library/papers/40108695PubMed
39736980Risk stratification and contributing factors of deep vein thrombosis among patients admitted at Debre Markos comprehensive specialized hospital, Ethiopia in 2024.Front Med (Lausanne)2024https://conductscience.org/library/papers/39736980PubMed
38893201Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines.Cancers (Basel)2024https://conductscience.org/library/papers/38893201PubMed
38507055Incidence and characteristic of deep venous thrombosis in hospitalized chronic heart failure patients.Heart Vessels2024https://conductscience.org/library/papers/38507055PubMed
38432204Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease Inpatients: Systematic Review and Meta-Analysis.Acta Haematol2024https://conductscience.org/library/papers/38432204PubMed
37150824The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy : A randomised controlled trial: open label.Thromb J2023https://conductscience.org/library/papers/37150824PubMed
36867519Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia.Ann Am Thorac Soc2023https://conductscience.org/library/papers/36867519PubMed
35898299Correlation of Inflammation and Coagulation Markers with the Incidence of Deep Vein Thrombosis in Cancer Patients with High Risk of Thrombosis.Int J Gen Med2022https://conductscience.org/library/papers/35898299PubMed
35595804The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure.Sci Rep2022https://conductscience.org/library/papers/35595804PubMed
35414101Evaluation of the Padua Prediction Score ability to predict venous thromboembolism in Israeli non-surgical hospitalized patients using electronic medical records.Sci Rep2022https://conductscience.org/library/papers/35414101PubMed
34878173Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34878173PubMed
34622445Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34622445PubMed
34327882Heart Failure Is Associated with Increased Risk of Long-Term Venous Thromboembolism.Korean Circ J2021https://conductscience.org/library/papers/34327882PubMed
33570602American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.Blood Adv2021https://conductscience.org/library/papers/33570602PubMed
32989908COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward.Clin Transl Sci2020https://conductscience.org/library/papers/32989908PubMed
32692862Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19.J Thromb Haemost2020https://conductscience.org/library/papers/32692862PubMed
32632822New insights on patient-related risk factors for venous thromboembolism in patients with solid organ cancers.Int J Hematol2020https://conductscience.org/library/papers/32632822PubMed
32540948Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow.BMJ Open Qual2020https://conductscience.org/library/papers/32540948PubMed
32442298Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.Blood Adv2020https://conductscience.org/library/papers/32442298PubMed

See all 64 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12945875

GET https://conductscience.org/api/papers/v1/12945875/cited_by?page=2